Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Authors:
- F ChevyFCF Chevy
- J PhamJPJ Pham
- M Kolf-ClauwMKM Kolf-Clauw
- D CitadelleDCD Citadelle
- N MulliezNMN Mulliez
- C RouxCRC Roux
Open Access
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 37 (6) , 1325-1333
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblastsClinica Chimica Acta, 1995
- Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.Journal of Clinical Investigation, 1995
- Abnormal bile acids in the Smith‐Lemli‐Opitz syndromeAmerican Journal of Medical Genetics, 1994
- Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz SyndromeNew England Journal of Medicine, 1994
- Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitroTeratology, 1990
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983
- Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiationBiochemistry, 1979
- Teratogenic action and embryo lethality of AY 9944R: Prevention by a hypercholesterolemia‐provoking dietTeratology, 1979
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964
- Cholesterol and Companions. IV. Oxidation of ▵7-Stenols with Selenium DioxideJournal of the American Chemical Society, 1953